UTI Inc. carries a market capitalization of 76.56B, placing it among publicly traded companies globally. Its enterprise value stands at 338.36B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 76.56B |
| Enterprise Value | 338.36B |
UTI Inc. currently has 19.58M shares outstanding.
| Shares Outstanding | 19.58M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 14.18, and the price-to-book ratio stands at -3.59.
| PE Ratio | N/A |
| PS Ratio | 14.18 |
| PB Ratio | -3.59 |
| P/TBV Ratio | 5.68 |
| P/FCF Ratio | 5.86 |
| P/OCF Ratio | -7.69 |
| EV / Sales | 16.89 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 5.70 |
UTI Inc. maintains a current ratio of 0.44, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 157.00, indicating elevated leverage, while an interest coverage ratio of -5.54 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.44 |
| Quick Ratio | 0.27 |
| Debt / Equity | 157.00 |
| Debt / EBITDA | -1.71 |
| Interest Coverage | -5.54 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -21.40 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 115.85 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.39 |
Over the trailing twelve months, UTI Inc. has paid 5.75B in income taxes, reflecting an effective tax rate of 156.62.
| Income Tax | 5.75B |
| Effective Tax Rate | 156.62 |
UTI Inc.'s stock has declined approximately -83.90947% over the past 52 weeks. The 50-day moving average sits at 15,462.20, while the 200-day moving average is 21,033.90.
| Beta (5Y) | N/A |
| 52-Week Price Change | -83.90947% |
| 50-Day Moving Average | 15,462.20 |
| 200-Day Moving Average | 21,033.90 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, UTI Inc. generated 20.04B in revenue and converted that into -41.63B in net income, yielding earnings per share of -2,229.05. EBITDA reached -51.81B, while operating income came in at -51.81B.
| Revenue | 20.04B |
| Gross Profit | -21.27B |
| Operating Income | -51.81B |
| Pretax Income | -35.88B |
| Net Income | -41.63B |
| EBITDA | -51.81B |
| EBIT | -51.81B |
| Earnings Per Share (EPS) | -2,229.05 |
UTI Inc. holds 34.32B in cash and equivalents against 88.59B in total debt, resulting in a net debt position of 51.59B. Total book value stands at -79.08B, with working capital of -70.50B providing operational flexibility.
| Cash & Cash Equivalents | 34.32B |
| Total Debt | 88.59B |
| Net Debt | 51.59B |
| Equity (Book Value) | -79.08B |
| Book Value Per Share | -4,233.92 |
| Working Capital | -70.50B |
UTI Inc. produced -36.96B in operating cash flow over the past twelve months. After subtracting -85.48B in capital expenditures, free cash flow totaled -122.44B - equivalent to -6,555.87 per share.
| Operating Cash Flow | -36.96B |
| Capital Expenditures | -85.48B |
| Free Cash Flow | -122.44B |
| FCF Per Share | -6,555.87 |
UTI Inc. operates with a gross margin of -106.14, reflecting its pricing power and cost economics. The operating margin of -258.57 and net profit margin of -207.74 provide insight into operational efficiency.
| Gross Margin | -106.14 |
| Operating Margin | -258.57 |
| Pretax Margin | -179.05 |
| Profit Margin | -207.74 |
| EBITDA Margin | -258.57 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -45.23 |
| FCF Yield | 17.08 |
UTI Inc.'s most recent stock split took place on November 8, 2018 with a 1:3 split ratio.
| Last Split Date | 11/8/2018 |
| Split Ratio | 1:3 |
UTI Inc. posts an Altman Z-Score of -0.63, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.63 |